Also if Resverlogix doesn't pay under the present terms they have to pay Zenith the equilivant of credit card interest rate of 20% per annum or 1.8% compounded monthly. So Hepalink doesn't like the arrangement between Resverlogix and Zenith because they will become share holders in Resverlogix but not Zenith and see a Royality structure that was set to fund Zenith which they are not a part of. I understand why Hepalink would object to this but am not sure if their deal is worth changing the Zenith structure. With two big hitters (Dart and NGN)already in the game, and they are apart of Zenith, I wonder what their take is on this. I may not have this right but it is a shot.